These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2051994)

  • 1. Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
    Jansen RW; Molema G; Pauwels R; Schols D; De Clercq E; Meijer DK
    Mol Pharmacol; 1991 Jun; 39(6):818-23. PubMed ID: 2051994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
    Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
    Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
    Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
    Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charge modification of plasma and milk proteins results in antiviral active compounds.
    Swart PJ; Harmsen MC; Kuipers ME; Van Dijk AA; Van Der Strate BW; Van Berkel PH; Nuijens JH; Smit C; Witvrouw M; De Clercq E; de Béthune MP; Pauwels R; Meijer DK
    J Pept Sci; 1999 Dec; 5(12):563-76. PubMed ID: 10628656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in affinity of anti-CD4 monoclonal antibodies predict their effects on syncytium induction by human immunodeficiency virus.
    Wilks D; Walker L; O'Brien J; Habeshaw J; Dalgleish A
    Immunology; 1990 Sep; 71(1):10-5. PubMed ID: 2210798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A polyanion binding site on the CD4 molecule. Proximity to the HIV-gp120 binding region.
    Parish CR; Low L; Warren HS; Cunningham AL
    J Immunol; 1990 Aug; 145(4):1188-95. PubMed ID: 2380554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion of human B cell lines with HIV-1 envelope-expressing T cells is enhanced by antigen-specific Ig receptors. Possible mechanism for elimination of gp120-specific B cells in vivo.
    Golding H; Dimitrov DS; Blackburn R; Manischewitz J; Blumenthal R; Golding B
    J Immunol; 1993 Mar; 150(6):2506-16. PubMed ID: 7680694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An anti-CD4 (CDR3-loop) monoclonal antibody inhibits human immunodeficiency virus type 1 envelope glycoprotein-induced apoptosis.
    Guillerm C; Robert-Hebmann V; Hibner U; Hirn M; Devaux C
    Virology; 1998 Sep; 248(2):254-63. PubMed ID: 9721234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination.
    Deckert PM; Ballmaier M; Lang S; Deicher H; Schedel I
    J Immunol; 1996 Jan; 156(2):826-33. PubMed ID: 8543839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry.
    Corbeau P; Benkirane M; Weil R; David C; Emiliani S; Olive D; Mawas C; Serre A; Devaux C
    J Immunol; 1993 Jan; 150(1):290-301. PubMed ID: 7678031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanine-rich oligonucleotide modified at the 5' terminal by dimethoxytrityl residue inhibits HIV-1 replication by specific interaction with the envelope glycoprotein.
    Agatsuma T; Yamamoto I; Furukawa H; Nishigaki T
    Antiviral Res; 1996 Jul; 31(3):137-48. PubMed ID: 8811198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-HIV-1 activity of combinations and covalent conjugates of negatively charged human serum albumins (NCAs) and AZT.
    Kuipers ME; Swart PJ; Witvrouw M; Esté JA; Reymen D; De Clercq E; Meijer DK
    J Drug Target; 1999; 6(5):323-35. PubMed ID: 10342381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibitory activity of polyhydroxycarboxylates derived from phenolic compounds against human immunodeficiency virus replication.
    Schols D; Wutzler P; Klöcking R; Helbig B; De Clercq E
    J Acquir Immune Defic Syndr (1988); 1991; 4(7):677-85. PubMed ID: 1675677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4.
    Cabrera C; Witvrouw M; Gutiérrez A; Clotet B; Kuipers ME; Swart PJ; Meijer DK; Desmyter J; De Clercq E; Esté JA
    AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1535-43. PubMed ID: 10580404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syncytium formation and destruction of bystander CD4+ cells cocultured with T cells persistently infected with human immunodeficiency virus as demonstrated by flow cytometry.
    Schols D; Pauwels R; Baba M; Desmyter J; De Clercq E
    J Gen Virol; 1989 Sep; 70 ( Pt 9)():2397-408. PubMed ID: 2789268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of anti-HIV activity of negatively charged albumins: biomolecular interaction with the HIV-1 envelope protein gp120.
    Kuipers ME; Huisman JG; Swart PJ; de Béthune MP; Pauwels R; Schuitemaker H; De Clercq E; Meijer DK
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(5):419-29. PubMed ID: 8605586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Virtual screening of small molecular HIV-1 entry inhibitor NC-2 targeting gp120 and its action mechanism].
    Duan H; Wang Y; Song D; Chen Z; Qiu J; Lu L; Jiang S; Liu S; Tan S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):826-31. PubMed ID: 23803191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1.
    Schols D; Pauwels R; Desmyter J; De Clercq E
    Virology; 1990 Apr; 175(2):556-61. PubMed ID: 1691563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of charge clustering on the anti-HIV-1 activity and in vivo distribution of negatively charged albumins.
    Beljaars L; Floris R; Berkhout B; Smit C; Meijer DK; Molema G
    Biochem Pharmacol; 2002 May; 63(9):1663-73. PubMed ID: 12007569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.